12.11
12-مارس-25 15:45:01
15 متأخرة بدقائق
الأسهم
+0.67
+5.86%
نطاق اليوم
11.47 - 12.38
ISIN
N/A
المصدر
NASDAQ
Replimune to Present at the 39th Annual J.P. Morgan Healthcare Conference
06 يناير 2021 07:00:01 بحسب Nasdaq GlobeNewswire
Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with Advanced Solid Tumors
05 يناير 2021 07:00:02 بحسب Nasdaq GlobeNewswire